0001209191-23-050298.txt : 20230921
0001209191-23-050298.hdr.sgml : 20230921
20230921165823
ACCESSION NUMBER: 0001209191-23-050298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230920
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHILIPS CRAIG W.
CENTRAL INDEX KEY: 0001441383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 231269627
MAIL ADDRESS:
STREET 1: C/O KINETA, INC.
STREET 2: 219 TERRY AVE. N., SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER NAME:
FORMER CONFORMED NAME: PHILIPS CRAIG
DATE OF NAME CHANGE: 20080729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KINETA, INC./DE
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: (206) 378-0400
MAIL ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-20
0
0001445283
KINETA, INC./DE
KA
0001441383
PHILIPS CRAIG W.
C/O KINETA, INC.
219 TERRY AVE. N., SUITE 300
SEATTLE
WA
98109
0
1
0
0
President
0
Common Stock
2023-09-20
4
P
0
600
2.5417
A
54911
D
Common Stock
2023-09-21
4
P
0
2900
2.4033
A
57811
D
Common Stock
34654
I
By Whetstone Ventures, LLC
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.50 to $2.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.3911 to $2.415, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Reporting Person is a member manager of Whetstone Ventures, LLC ("Whetstone") and shares voting and dispositive power over the shares held by Whetstone.
/s/ Pauline Kenny, as Attorney-in-Fact
2023-09-21